Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Stephen Saletan"'
Autor:
Jean-Francois Baladi, Giancarlo Benelli, Stephen Saletan, Nina Marinsek, Patrick Neven, R Degun, Guy Jerusalem, Fabrice Andre, Jie Zhang
Publikováno v:
Current Medical Research and Opinion. 30:1007-1016
International guidelines for hormone-receptor-positive (HR(+)), human epidermal growth factor receptor-2 negative (HER2(-)) advanced breast cancer (BC) recommend sequential lines of hormonal therapy (HT), and only recommend chemotherapy for patients
Autor:
Ashley B. Grossman, Edward M. Wolin, Nicola Fazio, Judith Klimovsky, Ashok Panneerselvam, Dan Granberg, Stephen Saletan
Publikováno v:
Chest. 143:955-962
Background The incidence of neuroendocrine tumors (NETs) has increased approximately fivefold since the 1980s. A similar increase in the incidence of lung NETs has been reported, but therapy has not been optimized. Methods This exploratory subanalysi
Autor:
Timothy J. Hobday, Stephen Saletan, Emilio Bajetta, Lowell B. Anthony, Thomas M. O'Dorisio, Ashok Panneerselvam, Daniel Castellano, Walter Kocha
Publikováno v:
The Oncologist. 18:46-53
Introduction. The incidence of colorectal neuroendocrine tumors (NETs) is increasing, and patients with this disease have particularly poor prognoses. Treatment options are limited, and survival times have not improved in the past decade. Methods. A
Autor:
Jean-Francois Ricci, Fabrice Andre, Jie Zhang, R Degun, Guy Jerusalem, Giancarlo Benelli, Stephen Saletan, Patrick Neven, Nina Marinsek
Publikováno v:
BMC Cancer
Background Healthcare resource utilization in breast cancer varies by disease characteristics and treatment choices. However, lack of clarity in guidelines can result in varied interpretation and heterogeneous treatment management and costs. In Europ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f236637438fd83abdd7b9dab4bea4cc
http://www.biomedcentral.com/1471-2407/15/787
http://www.biomedcentral.com/1471-2407/15/787
Autor:
David, Lebwohl, Ozlem, Anak, Tarek, Sahmoud, Judith, Klimovsky, Ingrid, Elmroth, Tomas, Haas, Joseph, Posluszny, Stephen, Saletan, William, Berg
Publikováno v:
Annals of the New York Academy of Sciences. 1291
Everolimus is a potent, oral inhibitor of the mammalian target of rapamycin (mTOR) that has been investigated in multiple clinical development programs since 1996. A unique collaboration between academic and pharmaceutical experts fostered research t
Autor:
Nicola, Fazio, Dan, Granberg, Ashley, Grossman, Stephen, Saletan, Judith, Klimovsky, Ashok, Panneerselvam, Edward M, Wolin
Publikováno v:
Chest. 143(4)
The incidence of neuroendocrine tumors (NETs) has increased approximately fivefold since the 1980s. A similar increase in the incidence of lung NETs has been reported, but therapy has not been optimized.This exploratory subanalysis evaluated the effi
Autor:
Matthew Taylor, J. Vieira, Tarek Sahmoud, L. Lewis, David Chandiwana, Stephen Saletan, J.F. Ricci
Publikováno v:
Value in Health. 15(7)
Autor:
John D. Hainsworth, Carlos Becerra, Ashok Panneerselvam, Stephen Saletan, Suayib Yalcin, Timothy J. Hobday
Publikováno v:
American Journal of Gastroenterology. 106:S85-S86